2seventy Bio, Inc.
https://www.2seventybio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From 2seventy Bio, Inc.
Stock Watch: Advanced Therapies Deliver Fourth-Quarter Flop
As drug pricing continues its ascent among hot button issues, the multi-million-dollar price tags for one-and-done advanced therapies, their justification and reimbursement all remain unaligned.
What Big Pharmas Are Looking For In Partners
With all signs pointing towards a year ripe with partnering opportunities, four big pharma dealmakers reveal what they are looking for.
Gilead Touts Catalyst-Rich 2024 Amid Sales Slump
The drug maker pointed to a variety of key trial readouts over the course of the year, including the pivotal study of its long-acting HIV PrEP injectable and Phase III updates for Trodelvy.
Encouraging Phase III Data For Blenrep But GSK Remains Cautious On Market Return
Data may prove too little too late for the antibody drug conjugate, as GSK takes a cautious stance over future commercial viability.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
- Gene Therapy, Cell Therapy
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice